Blauvelt, A., Stein Gold, L., Gooderham, M., Strober, B., Pinter, A., Carrascosa, J.-M., Gisondi, P., Bleier, J., Madden, C., Deherder, D., Gomez, N.N. and Warren, R.B. 2022. Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s67. DOI:https://doi.org/10.25251/skin.6.supp.67.